Knockout of SLC27A5 activates the KEAP1/NRF2 pathway [72], which is linked to chemoresistance in non-small cell lung cancer patients [73] and different types of cancer cell lines [74]. The gene discussed is KEAP1; the disease is non-small cell lung carcinoma.